NCT01375933View on ClinicalTrials.gov

A Comparability Study of the Phase 3 Lot and a Single Commercial Lot of NicVAX in Healthy Adult Smokers

PHASE3CompletedINTERVENTIONAL
Enrollment

260

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions
Smoking
Interventions
BIOLOGICAL

NicVAX Vaccine

NicVAX Vaccine given 6 times over 6 months

Trial Locations (6)

20850

NicVAX Investigator, Rockville

32935

NicVAX Investigator, Melbourne

35802

NicVAX Investigator, Huntsville

46601

NicVAX Investigator, South Bend

61602

NicVAX Investigator, Peoria

92018

NicVAX Investigator, San Diego

Sponsors
All Listed Sponsors
lead

Nabi Biopharmaceuticals

INDUSTRY

NCT01375933 - A Comparability Study of the Phase 3 Lot and a Single Commercial Lot of NicVAX in Healthy Adult Smokers | Biotech Hunter | Biotech Hunter